KATHMANDU, Feb 8: A total of 862,080 doses of the AstraZeneca vaccine against COVID-19, provided by the British government through COVID-19 Vaccines Global Access or COVAX facility, arrived in Nepal on Monday.
Dec 24: A three-dose course of AstraZeneca's (AZN.L) COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
Dec 22: AstraZeneca Plc (AZN.L) said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-specific vaccine.
KATHMANDU, Nov 1: A shipment of AstraZeneca vaccines against COVID-19 has arrived in Nepal from the Maldives. Nepal received 201,600 doses of vaccines last night from the Maldives under the COVAX facility.
LONDON, June 18 : AstraZeneca on Friday said the European Union had lost a legal case against the pharmaceutical firm over the supply of COVID-19 vaccines as a court in Brussels rejected an EU request for more deliveries by the end of June.
KATHMANDU, May 24: A British study has concluded the Astrazeneca vaccine to be effective against the new variant of the novel coronavirus (COVID-19) disease. According to the BBC, the vaccines developed by American companies like Pfizer, Oxford, and AstraZeneca are found to be effective against the contagious variant B.1.617.2 found in India.
EUROPE, April 27: The European Commission said on Monday it had launched legal action against AstraZeneca (AZN.L) for not respecting its contract for the supply of COVID-19 vaccines and for not having a "reliable" plan to ensure timely deliveries.
NEW DELHI, March 28: A World Health Organization (WHO)-backed programme to supply coronavirus vaccines to poorer countries expects that the Serum Institute of India (SII) will resume full deliveries of the AstraZeneca shot to it in May, UNICEF said on Saturday.
WASHINGTON, Mar 23: AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.
TAIPEI, March 22: Health care workers received the first shots in Taiwan’s COVID-19 vaccination drive Monday, beginning a campaign that won’t use supplies from China amid uneven distribution of the vaccines globally.
GENEVA, Feb 16: The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.
LONDON, Jan 4: Britain began vaccinating its population with Oxford University and AstraZeneca’s COVID-19 shot on Monday in a world first, racing to give protection to the elderly and vulnerable as a new surge of cases threatened to overwhelm hospitals.
ZURICH, Dec 31: Britain on Wednesday became the first country to approve AstraZeneca and Oxford University’s home-grown UK COVID-19 vaccine, adding an easy-to-manage shot to the arsenal of a nation desperate for pandemic relief.
LONDON, Dec 28: The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K. authorities this week, said Sunday that researchers believe the shot will be effective against a new variant of the virus driving a rapid surge in infections in Britain.
NEW DELHI/BENGALURU, Dec 7: India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world’s second-most affected country struggles to contain the outbreak.
LONDON, Oct 26: Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc, show it produces a robust immune response in elderly people, the group at highest risk, the Financial Times reported on Monday.
LONDON, Sept 13: AstraZeneca AZN.L has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.
LONDON, July 20: AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.